Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fructose ingestion acutely stimulates circulating FGF21 levels in humans
Jody Dushay, Elena Toschi, Emilie K. Mitten, et al.
Molecular Metabolism (2014) Vol. 4, Iss. 1, pp. 51-57
Open Access | Times Cited: 206

Showing 26-50 of 206 citing articles:

A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism
Ffolliott M. Fisher, Mi-Sung Kim, Ludivine Doridot, et al.
Molecular Metabolism (2016) Vol. 6, Iss. 1, pp. 14-21
Open Access | Times Cited: 143
Carbohydrate Sensing Through the Transcription Factor ChREBP
Paula Ortega-Prieto, Catherine Postic
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 142
Metabolic interplay between white, beige, brown adipocytes and the liver
Ludger Scheja, Jöerg Heeren
Journal of Hepatology (2016) Vol. 64, Iss. 5, pp. 1176-1186
Open Access | Times Cited: 141
Going Back to the Biology of FGF21: New Insights
Jo E. Lewis, Francis J. P. Ebling, Ricardo J. Samms, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 8, pp. 491-504
Open Access | Times Cited: 138
Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
Bhavna N. Desai, Garima Singhal, Mikiko Watanabe, et al.
Molecular Metabolism (2017) Vol. 6, Iss. 11, pp. 1395-1406
Open Access | Times Cited: 126
Metabolic Targets in Nonalcoholic Fatty Liver Disease
William P. Esler, Kendra K. Bence
Cellular and Molecular Gastroenterology and Hepatology (2019) Vol. 8, Iss. 2, pp. 247-267
Open Access | Times Cited: 122
Dietary stearic acid regulates mitochondria in vivo in humans
Deniz Senyilmaz, Daniel Pfaff, Sam Virtue, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 110
Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates
Anne‐Marie Lundsgaard, Andreas M. Fritzen, Kim A. Sjøberg, et al.
Molecular Metabolism (2016) Vol. 6, Iss. 1, pp. 22-29
Open Access | Times Cited: 109
Fibroblast growth factor 21 in non-alcoholic fatty liver disease
Bradley Tucker, Huating Li, Xiaoxue Long, et al.
Metabolism (2019) Vol. 101, pp. 153994-153994
Closed Access | Times Cited: 108
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity
Marja‐Riitta Taskinen, Sanni Söderlund, Leonie H. Bogl, et al.
Journal of Internal Medicine (2017) Vol. 282, Iss. 2, pp. 187-201
Open Access | Times Cited: 107
Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans
Jakob S. Hansen, Jens Otto Clemmesen, Niels H. Secher, et al.
Molecular Metabolism (2015) Vol. 4, Iss. 8, pp. 551-560
Open Access | Times Cited: 106
Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21
Eleni M. Domouzoglou, Katerina Κ. Naka, Antonios P. Vlahos, et al.
AJP Heart and Circulatory Physiology (2015) Vol. 309, Iss. 6, pp. H1029-H1038
Open Access | Times Cited: 106
AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients
Allegra Kaufman, Lubna Abuqayyas, William S. Denney, et al.
Cell Reports Medicine (2020) Vol. 1, Iss. 4, pp. 100057-100057
Open Access | Times Cited: 102
Hepatokines: unlocking the multi-organ network in metabolic diseases
Alison Iroz, Jean‐Pierre Couty, Catherine Postic
Diabetologia (2015) Vol. 58, Iss. 8, pp. 1699-1703
Open Access | Times Cited: 96
Intestinal Fructose and Glucose Metabolism in Health and Disease
Beatriz Merino, Cristina M. Fernández-Díaz, Irene Cózar‐Castellano, et al.
Nutrients (2019) Vol. 12, Iss. 1, pp. 94-94
Open Access | Times Cited: 94
Fibroblast growth factor 21 night watch: advances and uncertainties in the field
Alexei Kharitonenkov, Richard D. DiMarchi
Journal of Internal Medicine (2016) Vol. 281, Iss. 3, pp. 233-246
Open Access | Times Cited: 93
Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans
Amos Baruch, Chin Wong, Leslie W. Chinn, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 46, pp. 28992-29000
Open Access | Times Cited: 79
FGF21 and the Physiological Regulation of Macronutrient Preference
Cristal M. Hill, Emily Qualls‐Creekmore, Hans‐Rudolf Berthoud, et al.
Endocrinology (2020) Vol. 161, Iss. 3
Open Access | Times Cited: 78
The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model
Redin A. Spann, Christopher D. Morrison, Laura J. den Hartigh
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 44
FGF21 counteracts alcohol intoxication by activating the noradrenergic nervous system
Mihwa Choi, Marc Schneeberger, Wei Fan, et al.
Cell Metabolism (2023) Vol. 35, Iss. 3, pp. 429-437.e5
Open Access | Times Cited: 27
Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice
Jia Nuo Feng, Weijuan Shao, Lin Yang, et al.
Nutrition and Diabetes (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Functions of FGF21 and its role in cardiac hypertrophy
Lei Chen, Meng Gao, Sang‐Bing Ong, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Intestinal, but not hepatic, ChREBP is required for fructose tolerance
Mi-Sung Kim, Inna Astapova, Sarah N. Flier, et al.
JCI Insight (2017) Vol. 2, Iss. 24
Open Access | Times Cited: 84
Fructose Metabolism and Relation to Atherosclerosis, Type 2 Diabetes, and Obesity
Astrid Kolderup, B. Svihus
Journal of Nutrition and Metabolism (2015) Vol. 2015, pp. 1-12
Open Access | Times Cited: 81
FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest
Susanna Søberg, Emilie S. Andersen, Niels B. Dalsgaard, et al.
Molecular Metabolism (2018) Vol. 11, pp. 96-103
Open Access | Times Cited: 76

Scroll to top